Previous Page  38 / 218 Next Page
Information
Show Menu
Previous Page 38 / 218 Next Page
Page Background

36

Chapter 2

Box 2.2 | Dopamine

Neuroimaging tools (e.g. functional MRI (fMRI);

box 2.4

and TMS;

box 2.5

) provide

valuable insight in the brain regions involved in the execution of tasks or in the connectivity

between regions. Although fMRI BOLD might correlate with changes in dopamine

(Knutson and Gibbs, 2007) and TMS can induce changes in dopamine release in the

striatum (Strafella et al., 2003), these methods alone do not provide direct evidence for the

involvement of any given neurotransmitter system. Ideally then, to assess the involvement

of dopamine in the anticipation of reward, one would want to administer a drug that

manipulates the dopamine system.

Axon

terminal

of a

dopamine

neuron

VTA/SN

dopamine

post-synaptic dopamine D1 receptor

post-synaptic dopamine D2 receptor

pre-synaptic dopamine D2 receptor

dopamine transporter (DAT)

Post-synaptic: Striatal MSN neuron

Glutamatergic neuron

PFC

Bromocriptine

(high dose)

Methylphenidate

Bromocriptine

(low dose)

B

D

C

E

A

is gure was inspired by: Marieke van der Schaaf (2014)

Dopaminergic modulation of reward and punishment learning (PhD thesis)

more inhibition of the cortex

e.g. enhanced exible behavior

blocking bromocriptine -

induced e ects

e.g. no longer enhanced

exible behavior

less inhibition of the cortex

e.g. favoring stable

representations

more inhibition of the cortex

e.g. enhanced exible behavior

Sulpiride